Reflux esophagitis is an esophageal mucosal injury that occurs secondary to retrograde flux of gastric contents into the esophagus. Clinically, this is referred to as gastroesophageal reflux disease (GERD).
Fig: Esophagitis
Which PPI is Superior?
Some of the present study demonstrated that Esomeprazole gave faster symptom relief
in patients with Reflux Esophagitis than pantoprazole, lansoprazole and
omeprazole.
Esomeprazole can effectively relieve symptoms
of esophagitis (e.g., heartburn) and promote healing of ulcerative and erosive
lesions. Because esomeprazole (S-omeprazole)
is not eliminated as rapidly as R-omeprazole, more drug reaches and blocks the
proton pump, providing greater control of intragastric pH than
racemic omeprazole.
Because:
Esomeprazole has been shown to have a faster onset of
anti-secretory activity than omeprazole, lansoprazole and pantoprazole.
In conclusion, the present study found that
esomeprazole 40 mg daily may be more effective than either omeprazole 20 mg
daily, pantoprazole 40 mg daily or lansoprazole 30 mg daily for the rapid
relief of heartburn symptoms in patients with endoscopically proven reflux
esophagitis.
Esomeprazole magnesium is
used for short-term (4-8 weeks) treatment of diagnostically confirmed erosive
esophagitis in patients with gastroesophageal reflux disease (GERD). The drug
also is used as maintenance therapy following healing of erosive esophagitis to
reduce recurrence of the disease.
In addition, esomeprazole is
used for short-term (4-8 weeks) treatment of symptoms (e.g., heartburn) of GERD
in patients without erosive esophagitis. In infants, esomeprazole is
used for short-term (up to 6 weeks) treatment of erosive esophagitis due to
acid-mediated GERD.
Note: For informational purposes only. Consult your
textbook for advising your patients.
Comments
You must login to write comment